Lissamine Green Ophthalmic Strips — sterile diagnostic strips staining degenerated and devitalised conjunctival cells, the standard for dry-
Lissamine Green Ophthalmic Strips — sterile diagnostic strips staining degenerated and devitalised conjunctival cells, the standard for dry-eye and ocular surface disease evaluation. GMP manufactured with batch COA.
| Product Name | Lissamine Green Ophthalmic Strips (Diagnostic) |
|---|---|
| Dosage Form | Diagnostic strip |
| Strength | 1.5 mg lissamine green per sterile strip |
| Standards | BP / ENTERPRISE |
| Packing | Individually sterile-packed strips, 100 strips/box |
| Documents | COA, COPP, DMF, CTD Dossiers |
| MOQ | Contact us for MOQ and current stock |
Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.
Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.
Full batch testing and quality traceability under standard GMP workshops.
Sufficient stock on regular items, familiar with export logistics to 50+ countries.
COA, DMF, dossier and legalization documents for your market registration.
Artemisine Medicines